Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00120939
Recruitment Status : Completed
First Posted : July 19, 2005
Last Update Posted : April 3, 2009
Information provided by:
Pharmacyclics LLC.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Study Completion Date : No date given